Vibalogics (now part of Recipharm) is a full-service CDMO offering process technical transfer, development, GMP manufacturing, testing and fill-finish services to innovators developing virotherapies. Through a comprehensive set of clinical- and commercial-enabling service offerings, we partner with our clients to support early-to-late stage success. Built on a foundation of robust industry-leading scientific expertise, quality systems and global regulatory compliance, we deliver manufactured products with a complementing customer service experience that is customer friendly, communication-forward, transparent and flexible. Service Offerings: GMP Cell Banking | GMP Viral Banking | Technical Transfer | Process & Analytical Development | GMP Drug Substance Manufacture | GMP Drug Product Manufacture | Formulation, Fill & Finish | Lot / Batch Release | Stability Studies Product Experience Includes: Live Viruses | Viral Vectors | Oncolytic Viruses | Gene Therapy | Vaccines | Adenovirus (Primate & Human) | Adeno-Associated (AAV) | Dengue | Herpes (HSV, Marek Disease, CMV) | Influenza (Flu) | Infectious Bursal Disease (IBDV) | Measles (Rubeola) | Newcastle Disease (NDV) | Poxviruses | Porcine Reproductive Respiratory Syndrome (PRRSV) | Respiratory-Syncitial Virus (RSV) | Vaccinia (VACV/MVA) | Vesicular Stomatitis Virus (VSV)
Looking for a particular Vibalogics employee's phone or email?
The Vibalogics annual revenue was $19.4 million in 2026.
Paul Rodriguez is the Director Of Manufacturing Operations of Vibalogics.
32 people are employed at Vibalogics.
Vibalogics is based in Cuxhaven, Lower Saxony.
The NAICS codes for Vibalogics are [325414, 32, 32541, 54, 541, 325, 3254].
The SIC codes for Vibalogics are [28, 873, 283, 87].